Recombinant Human Soluble Thrombomodulin is Effective for Severe Childhood EBV-HLH
Journal Title: Journal of Hematology & Thrombosis - Year 2016, Vol 2, Issue 1
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a fatal disease, presenting with T cell-induced dysregulated cytokine production, systemic inflammation, and frequently intractable coagulopathy. We have administered recombinant human soluble recombinant thrombomodulin (rTM) for four cases of severe childhood Epstein-Barr virus-associated HLH (EBV-HLH) in combination with anti-inflammatory therapy and had good clinical outcomes. To evaluate its efficacy, we retrospectively compared to the former six cases without rTM administration. The patients were admitted between May 2003 and July 2014. The median age at diagnosis was 8.2 years (range, 1.6-16 years). All patients except for two cases without rTM who received only steroid, were treated with steroid, cyclosporine A (CSP) and/or etoposide based on HLH-94 or HLH-2004. All patients receiving rTM were induced in remission. However, two patients without rTM administration died of disease progression. The values of FDP, D-dimer, serum ferritin, and bilirubin improved better in patients with rTM. In some cases without rTM, serum bilirubin increased even though D-dimer, FDP, and ferritin were decreased. Although further clinical experience is required, rTM may be effective as an adjuvant therapy for resolution of severe EBV-HLH.
Authors and Affiliations
Masayuki Nagasawa
Keywords
Related Articles
- EP ID EP246530
- DOI 10.13188/2380-6842.1000012
- Views 155
- Downloads 0
The Application of Holotranscobalamin and Methylmalonic Acid in Hospital Patients and Total Vitamin B12 in Primary Care Patients to Assess Low Vitamin B12 Status
Background: Low vitamin B12 (B12) status is common in patient populations. The timely detection and correction of low B12 prevents megaloblastic anaemia and neurological impairment. However, prompt diagnosis is recognise...
Large Granular Lymphocytic Leukemia and Cocaine Abuse in A Patient With Chronic Neutropenia - Are They Co-Existing or Causally Related?
Chronic neutropenia is a hematological condition that could cause significant morbidity due to recurrent infections. Various benign and malignant disorders manifest with chronic neutropenia and a meticulous evaluation is...
Provisional Study of Kuwait Adult Hematology Reference Range
Introduction: Hematology reference range provides valuable information for the correct interpretation of results for proper diagnosis and treatment. Previous studies have shown that hematology reference range may vary in...
Recombinant Human Soluble Thrombomodulin is Effective for Severe Childhood EBV-HLH
Hemophagocytic lymphohistiocytosis (HLH) is a fatal disease, presenting with T cell-induced dysregulated cytokine production, systemic inflammation, and frequently intractable coagulopathy. We have administered recombina...
Evaluation of Schistocytosis in Patients Treated with Dialysis
Schistocytes are associated with micro angiopathic hemolytic processes. In this retrospective study; we evaluate the association ofschistocytosis in the peripheral blood smear of patients before and after dialysis. We id...